Table 1 Characteristics of levofloxacin-treated patients with ≥1 isolate of Enterobacteriaceae identified at baseline (mMITT population)
Characteristic | Levofloxacin N = 370 |
|---|---|
Age, years | |
Mean (SD) | 48.0 (20.26) |
Range, n (%) | 18–87 |
≥ 65–< 75 | 47 (12.7) |
≥ 75 | 43 (11.6) |
Sex, n (%) | |
Male | 82 (22.2) |
Female | 288 (77.8) |
Race, n (%) | |
White | 317 (85.7) |
Black or African American | 6 (1.6) |
Asian | 30 (8.1) |
Other | 17 (4.6) |
Region, n (%) | |
Eastern Europe | 277 (74.9) |
Western Europe | 0 |
North America | 9 (2.4) |
South America | 39 (10.5) |
Rest of world | 45 (12.2) |
Diagnosis, n (%) | |
Pyelonephritis | 306 (82.7) |
cLUTI | 64 (17.3) |
Creatinine clearance, mL/min, n (%) | |
Normal (≥80) | 250 (67.6) |
Mild impairment (≥50–< 80) | 92 (24.9) |
Moderate impairment (≥30–< 50) | 27 (7.3) |
Severe impairment (<30) | 1 (0.3) |